Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BEZAFIBRATE for Cholangitis sclerosing: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where BEZAFIBRATE was used for Cholangitis sclerosing.

Most Reported Side Effects for BEZAFIBRATE

Side Effect Reports % Deaths Hosp.
Myalgia 29 9.5% 0 6
Abdominal pain 25 8.2% 0 10
Rhabdomyolysis 21 6.9% 0 17
Back pain 20 6.6% 0 4
Blood creatine phosphokinase increased 19 6.2% 0 5
Acute myocardial infarction 17 5.6% 0 3
Pancreatitis acute 17 5.6% 0 17
Pyrexia 16 5.3% 0 2
Acute coronary syndrome 15 4.9% 0 1
Drug intolerance 15 4.9% 0 0
Hypertension 15 4.9% 0 1
Off label use 15 4.9% 1 2
Pulmonary embolism 15 4.9% 1 15
Arthralgia 14 4.6% 1 2
Carotid arteriosclerosis 14 4.6% 0 0

Other Indications for BEZAFIBRATE

Product used for unknown indication (97) Dyslipidaemia (44) Hyperlipidaemia (35) Hypercholesterolaemia (26) Blood cholesterol increased (13) Primary biliary cholangitis (13) Blood cholesterol (7) Cholangitis (6) Type iia hyperlipidaemia (6)

Other Drugs Used for Cholangitis sclerosing

URSODIOL (82) MYCOPHENOLATE MOFETIL (52) PREDNISOLONE (41) AZATHIOPRINE (40) PREDNISONE (38) INFLIXIMAB (31) TACROLIMUS (29) ADALIMUMAB (23) METHYLPREDNISOLONE (23) MESALAMINE (20)

Related Pages

BEZAFIBRATE Full Profile All Cholangitis sclerosing Drugs BEZAFIBRATE Demographics BEZAFIBRATE Timeline